Vα24+ natural killer T-cell responses against T-acute lymphoblastic leukaemia cells: Implications for immunotherapy

British Journal of Haematology

Volumn 122, Issue 2, 2003, Pages 231-239

  Takahashi, Tsuyoshi ^a   Haraguchi, Kyoko ^a,b   Chiba, Shigeru ^a   Yasukawa, Masaki ^c   Shibata, Yoichi ^a   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

galactosylceramide; Human; Immunotherapy; T ALL; V 24+ NKT

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHROMIUM 51; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; CD1 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CHILD; CLINICAL ARTICLE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; LEUKEMIA CELL; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; T CELL LEUKEMIA; T LYMPHOCYTE SUBPOPULATION; ADOPTIVE IMMUNOTHERAPY; CELL CULTURE; CYTOTOXICITY TEST; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METHODOLOGY;

ANTIGENS, CD1; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, NATURAL; LEUKEMIA, T-CELL, ACUTE; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TUMOR CELLS, CULTURED;

EID: 0038824943     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04429.x     Document Type: Article

References (39)

1. + T cells. Current Opinion in Immunology, 7, 367-374.
2. + thymocytes selected by MHC class I molecules. Science, 263, 1774-1778.
3. Bendelac, A., Rivera, M.N., Park, S.H. & Roark, J.H. (1997) Mouse CD1-specific NK1 T cells: development, specificity, and function. Annual Review of Immunology, 15, 535-562.
4. Brossay, L., Jullien, D., Cardell, S., Sydora, B.C., Burdin, N., Modlin, R.L. & Kronenberg, M. (1997) Mouse CD1 is mainly expressed on hemopoietic-derived cells. Journal of Immunology, 159, 1216-1224.
5. Brossay, L., Chioda, M., Burdln, N., Koezuka, Y., Casorati, G., Dellabona, P. & Kronenberg, M. (1998) CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. Journal of Experimental Medicine, 188, 1521-1528.
6. Budd, R.C., Miescher, G.C., Howe, R.C., Lees, R.K., Bron, C. & MacDonald, H.R. (1987) Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocites. Journal of Experimental Medicine, 166, 577-582.
7. Carnaud, C., Lee, D., Donnars, O., Park, S.H., Beavis, A., Koezuka, Y. & Bendelac, A. (1999) Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. Journal of Immunology, 163, 4647-4650.
8. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. Journal of Immunology, 159, 2240-2249.
9. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M. & Taniguchi, M. (1997) Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science, 278, 1623-1626.
10. Davodeau, F., Peyrat, M.A., Necker, A., Dommici, R., Blanchard, F., Leget, C., Gaschet, J., Costa, P., Jacques, Y., Godard, A., Vie, H., Poggi, A., Romagne, F. & Bonneville, M. (1997) Close phenotypic and functional similarities between human and murme αβ T cells expressing invariant TCR α-chains. Journal of Immunology, 158, 5603-5611.
11. - T cells. Journal of Experimental Medicine, 180, 1171-1176.
12. Eberl, G. & MacDonald, H.R. (2000) Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. European Journal of Immunology, 30, 985-992.
13. - T cells. Journal of Experimental Medicine, 186, 109-120.
14. Exley, M., Garcia, J., Wilson, S.B., Spada, F., Gerdes, D., Tahir, S.M., Patton, K.T., Blumberg, R.S., Porcelli, S., Chott, A. & Balk, S.P. (2000) CD1d structure and regulation on human thymocytes. peripheral blood T cells, B cells and monocytes. Immunology, 100. 37-47.
15. Fowlkes, B.J., Kruisbeek, A.M., Ton-That, H., Weston, M.A., Coligan, J.E., Schwartz, R.H. & Pardoll, D.M. (1987) A novel population of T cell receptor αβ-bearing thymocytes which predominantly expresses a single Vβ8 gene family. Nature, 329, 251-254.
16. Gumperz, J.E., Miyake, S., Yamamura, T. & Brenner, M.B. (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. Journal of Experimental Medicine, 195, 625-636.
17. Karadimitris, A., Gadola, S., Altamirano, M., Brown, D., Woolfson, A., Klenerman, P., Chen, J.L., Koezuka, Y., Roberts, I.A., Price, D.A., Dusheiko, G., Milstein, C., Fersht, A., Luzzatto, L. & Cerundolo, V. (2001) Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proceedings of the National Academy of Sciences of the United States of America, 98, 3294-3298.
18. α14 NKT cells by glycosylceramides. Science, 278, 1626-1629.
19. Kawano, T., Nakayama, T., Kamada, N., Kaneko, Y., Harada, M., Ogura, N., Akutsu, Y., Motohashi, S., Iizasa, T., Endo, H., Fujisawa, T., Shinkai, H. & Taniguchi, M. (1999) Antitumor cytotoxicity mediated by ligand-activated human Vα24 NKT cells. Cancer Research, 59, 5102-5105.
20. - T cells in mice and humans. Journal of Experimental Medicine, 180, 1097-1106.
21. Lee, P.T., Benlagha, K., Teyton, L. & Bendelac, A. (2002) Distinct functional lineages of human Vα24 natural killer T cells. Journal of Experimental Medicine, 195, 637-641.
22. + T cell receptor α/β cells: new clues to their origin, specificity, and function. Journal of Experimental Medicine, 182, 633-638.
23. Metelitsa, L.S., Naidenko, O.V., Kant, A., Wu, H.W., Loza, M.J., Perussia, B., Kronenberg, M. & Seeger, R.C. (2001) Human NKT cells mediate antitumor cytotoxicity directly by recognizing target ceil CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. Journal of Immunology, 167, 3114-3122.
24. Moodycliffe, A.M., Nghiem, D., Clydesdale, G. & Ullrich, S.E. (2000) Immune suppression and skin cancer development: regulation by NKT cells. Nature Immunology, 1, 521-525.
25. Nakagawa, R., Motoki, K., Ueno, H., Iijima, R., Nakamura, H., Kobayashi, E., Shimosaka, A. & Koezuka, Y. (1998) Treatment of hepatic metastasis of the colon26 adenocarcinoma with an α-galactosylceramide. KRN7000. Cancer Research, 58, 1202-1207.
26. + natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumor activity through mechanisms distinct from T cells and natural killer cells. Immunology, 99, 229-234.
27. Nieda, M., Nicol, A., Koezuka, Y., Kikuchi, A., Takahashi, T., Nakamura, H., Furukawa, H., Yabe, T., Ishikawa, Y., Tadokoro, K. & Juji, T. (1999) Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner. Human Immunology, 60, 10-19.
28. Nieda, M., Nicol, A., Koezuka, Y., Kikuchi, A., Lapteva, N., Tanaka, Y., Tokunaga, K., Suzuki, K., Kayagaki, N., Yagita, H., Hirai, H. & Juji, T. (2001) TRAIL expression by activated human CD4(+) V alpha 24 NKT cells induce in vitro and in vivo apoptosis of human acute myeloid leukemia cells. Blood, 97, 2067-2074.
29. Nishimura, T., Kitamura, H., Iwakabe, K., Yahata, T., Ohta, A., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., Kawano, T., Taniguchi, M., Nakui, M., Sekimoto, M. & Koda, T. (2000) The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. International Immunology, 12, 987-994.
30. - and heterogenous with respect to TCRβ expression. Human Immunology, 48, 63-67.
31. Prussin, C. & Foster, B. (1997) TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. Journal of Immunology, 159, 5862-5870.
32. Roark, J.H., Park, S.H., Jayawardena, J., Kavita, U., Shannon, M. & Bendelac, A. (1998) CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. Journal of Immunology, 160, 3121-3127.
33. Smyth, M.J., Thia, K.Y., Street, S.E., Cretney, E., Trapani, J.A., Taniguchi, M., Kawano, T., Pelikan, S.B., Crowe, N.Y. & Godfrey, D.I. (2000) Differential rumor surveillance by natural killer (NK) and NKT cells. Journal of Experimental Medicine, 191, 661-668.
34. Spada, M., Koezuka, Y. & Porcelli, S. (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. Journal of Experimental Medicine, 188, 1529-1534.
35. Spada, F.M., Borriello, F., Sugita, M., Watts, G.F.M., Koezuka, Y. & Porcelli, S.A. (2000) Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. European Journal of Immunology, 30, 3468-3477.
36. + NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells. Journal of Immunology, 164, 4458-4464.
37. + NKT cells activated by α-galactosylcera-mide-pulsed monocyte-derived dendritic cells. Journal of Immunology, 168, 3140-3144.
38. Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D.D., Carbone, D.P., Paul, W.E. & Berzofsky, J.A. (2000) NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nature Immunology, 1, 515-520.
39. Toura, I., Kawano, T., Akutsu, Y., Nakayama, T., Ochiai, T. & Taniguchi, M. (1999) Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. Journal of Immunology, 163, 2387-2391.